K2 Principal Fund’s Kite Pharma, Inc. KITE Stock Holding History

K2 Principal Fund’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-47,940	Closed	-$8.62M	–	409
2017 Q3	$8.62M	Buy	+47,940	New	+$6.68M	0.57%	48

K2 Principal Fund's KITE Position: Q4 2017 in Review

K2 Principal Fund sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 47,940 shares — an estimated $8.62M sold.

K2 Principal Fund first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $8.62M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

K2 Principal Fund reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
K2 Principal Fund sold 47,940 Kite Pharma, Inc. shares in Q4 2017, an estimated $8.62M.
K2 Principal Fund first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
K2 Principal Fund's Kite Pharma, Inc. position peaked at $8.62M in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on K2 Principal Fund's 13F filing for Q4 2017, filed 12 Feb 2018.